Autres langues IM Cannabis Corp. Nasdaq

Actions

IMCC

CA44969Q3070

Temps réel estimé Cboe BZX Autres places de cotation 16:13:35 24/05/2024			Varia. 5j.	Varia. 1 janv.
0,611 ^USD	+3,56 %		-14,08 %	+70,87 %

08/05	Transcript : IM Cannabis Corp., Q1 2024 Earnings Call, May 08, 2024
08/05	IM Cannabis Corp. annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

IM Cannabis : Transcript	08/05
IM Cannabis : Financial Statements Q1 2024	08/05
IM Cannabis : Management's Discussion and Analysis Q1 2024	08/05
IM Cannabis Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024	08/05
IM Cannabis : MONTHLY PROGRESS REPORT - Form 6-K	06/05
IM Cannabis Corp. and Vessel Brand, Inc. Partner to Bring Vessel Cannabis Accessories to the Israeli Market	09/04
IM Cannabis, Avant Brands Sign BLK MKT's Licensing Deal for German Medical Cannabis Market	04/04
IM Cannabis : MONTHLY PROGRESS REPORT - Form 6-K	04/04
IM Cannabis Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	28/03
IM Cannabis Corp. Brief: Notes This Provides IMC Germany with a "Unique Opportunity" to further accelerate growth in 2024 after delivering 180% growth in 2023	25/03
IM Cannabis Corp. Brief: Adds By rescheduling medical cannabis, from a narcotic to a regular prescription, the German medical cannabis market is Expected to deliver "Strong" growth	25/03
IM Cannabis Corp. Brief: Says Expects "Accelerated Growth" in Germany from that Country's "Groundbreaking" Cannabis Legalization	25/03
IM Cannabis Corp. Announces German Government's Final Approval of Legalizing Cannabis	25/03
IM Cannabis : MONTHLY PROGRESS REPORT - Form 6-K	06/03
IMC Announces Potential Reverse Merger With A Leading Clinical Cell Therapy Company	28/02
IMC Announces Potential Reverse Merger with Kadimastem a leading Clinical cell therapy company	28/02
Kadimastem Ltd entered into a non-binding term sheet to acquire IM Cannabis Corp. in reverse merger transaction.	28/02
Avant Brands Brief: Restructuring Loan Agreements to Extend Term and Decrease Payments	26/02
IM Cannabis Brief: Says Received 180 Calendar Day Extension from Nasdaq Stock Market to Regain Compliance with Bid Price Rule	31/01
IMC Reschedules the Final Payment of the Oranim Pharmacy Acquisition	15/01

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues IM Cannabis Corp. Nasdaq

Actions

IMCC

CA44969Q3070

Autres langues

Filtres